| Subjects |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Managing Expectations |
|
Subjects - Managing Expectations
The art and science behind making commitments and managing expectations has always been a critical skill set for senior executives and entrepreneurs to master. In fact, understanding how to come out on the According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product right-side of the expectation curve can often be the difference between average performers and superstars. This is evidenced by the fact that the consulting industry has zeroed in on the importance of this ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ssue such that it has evolved into an emerging discipline known as ”Promise Management”. In this blog post I’ll discuss the value of promise management as a discipline. Nothing engenders confidence and cre lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ates a trust bond like delivering on promises made and likewise few things erode confidence and credibility like commitments not kept. In a previous post entitled: “Follow Through” I discussed the importanc here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe of saying what you mean, meaning what you say and doing what you say you’ll do. The science of promise management is systematically connecting what is said with what is done. The art of promise management d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro is closing, or better yet, eliminating the expectation gap. Blend the art and science together and you have the framework for what is becoming the differentiating factor in performance based decisioning for ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc the twenty-first century. Conflicts, disagreements, disputes and litigation are often born out of expectation gaps. Expectations cut both ways…Keeping what you perceive as being your end of the bargain is easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi only half of the equation as what you think only matters if it is in alignment with the understanding of the other party. We have all found ourselves in the unenviable position of assigning work product onl nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically to end-up with the deliverable falling far short of expectations while having the producer of said work product thinking they exceeded all expectations. Expectations exist throughout the entire value chai and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ n with every stakeholder needing and deserving to have their expectations managed and met. Whether it is managing customer expectations, shareholder or analyst expectations, or the inverse of employees havi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi g to deal with the expectations of executives, it is the ability to excel at decisioning based upon managing expectations that creates high performance organizations. Promises that are made based upon soli ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a d reasoning and underlying business logic that are consistently kept will help to create a solid brand attracting loyal customers and talented employees. The following three practices will help create an or dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod anization that delivers on its commitments: 1. Collaborate early and often: Decisioning in a vacuum or without all the facts will place you in a deficit from the beginning. It is at best extremely d cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ifficult to manage expectations and deliver on commitments made if you don’t have clear visibility as to what is wanted or needed. Before making promises or commitments collaborate with all concerned partie tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen to insure that expectations are understood. 2. Resist making verbal commitments: Most misunderstandings occur as a result of improper interpretation of oral communications. Most broken commitments t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel result from impulsive verbal promises made before all the details were sorted out. Once you have gained clarity as to the perceived need to be fulfilled place your understanding of the deliverables in writi ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust g by outlining key business points and circulate the document for review and comments. Where possible resist formalizing agreements, proposals, or other commitments until you have alignment on key expectati y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ons and deliverables. 3. Manages promises like projects: Build a culture that breaks down all commitments made into deliverables, benchmarks and deadlines. Allocate resources, budget and staff while . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de managing the commitment within a framework of measured accountability. Treating all commitments and promises as formal projects will help manage performance risk and will also create continuity of process a elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip nd delivery. Performance based decisioning based upon principles of promise management will lead to a certainty of execution that should translate into one of your company’s greatest competitive advantages tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Improve Your Job Search if You're a Top Sales and Marketing Executive 15 Principles for Complete Customer Service Holding A Fund Raising Cookout for a Good Cause
|